These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36873460)

  • 1. Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension.
    Philip N; Pi H; Gadkari M; Yun X; Huetsch J; Zhang C; Harlan R; Roux A; Graham D; Shimoda L; Le A; Visovatti S; Leary PJ; Gharib SA; Simpson C; Santhanam L; Steppan J; Suresh K
    Pulm Circ; 2023 Jan; 13(1):e12205. PubMed ID: 36873460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension.
    Philip N; Yun X; Pi H; Murray S; Hill Z; Fonticella J; Perez P; Zhang C; Pathmasiri W; Sumner S; Servinsky L; Jiang H; Huetsch JC; Oldham WM; Visovatti S; Leary PJ; Gharib SA; Brittain E; Simpson CE; Le A; Shimoda LA; Suresh K
    Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L252-L265. PubMed ID: 38226418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of mitochondrial fragmentation in microvascular endothelial cells isolated from the SU5416/hypoxia model of pulmonary arterial hypertension.
    Suresh K; Servinsky L; Jiang H; Bigham Z; Zaldumbide J; Huetsch JC; Kliment C; Acoba MG; Kirsch BJ; Claypool SM; Le A; Damarla M; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L639-L652. PubMed ID: 31461316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species induced Ca
    Suresh K; Servinsky L; Jiang H; Bigham Z; Yun X; Kliment C; Huetsch J; Damarla M; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L893-L907. PubMed ID: 29388466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Aquaporin 1 Mediates Increased Migration and Proliferation in Pulmonary Vascular Cells From the Rat SU5416/Hypoxia Model of Pulmonary Hypertension.
    Yun X; Philip NM; Jiang H; Smith Z; Huetsch JC; Damarla M; Suresh K; Shimoda LA
    Front Physiol; 2021; 12():763444. PubMed ID: 34975522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension.
    Gomez-Puerto MC; Sun XQ; Schalij I; Orriols M; Pan X; Szulcek R; Goumans MJ; Bogaard HJ; Zhou Q; Ten Dijke P
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of lung microvascular endothelial Piezo2 expression impairs NO synthesis, induces EndMT, and is associated with pulmonary hypertension.
    Tian S; Cai Z; Sen P; van Uden D; van de Kamp E; Thuillet R; Tu L; Guignabert C; Boomars K; Van der Heiden K; Brandt MM; Merkus D
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H958-H974. PubMed ID: 36149769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension.
    Spyropoulos F; Michael Z; Finander B; Vitali S; Kosmas K; Zymaris P; Kalish BT; Kourembanas S; Christou H
    Front Cardiovasc Med; 2021; 8():662870. PubMed ID: 34222363
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension.
    Chouvarine P; Giera M; Kastenmüller G; Artati A; Adamski J; Bertram H; Hansmann G
    Heart; 2020 Sep; 106(17):1332-1341. PubMed ID: 32079620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension.
    Simpson CE; Ambade AS; Harlan R; Roux A; Graham D; Klauer N; Tuhy T; Kolb TM; Suresh K; Hassoun PM; Damico RL
    Pulm Circ; 2023 Jul; 13(3):e12260. PubMed ID: 37404901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
    Honda Y; Kosugi K; Fuchikami C; Kuramoto K; Numakura Y; Kuwano K
    PLoS One; 2020; 15(10):e0240692. PubMed ID: 33057388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension.
    Poble PB; Phan C; Quatremare T; Bordenave J; Thuillet R; Cumont A; Huertas A; Tu L; Dorfmüller P; Humbert M; Ghigna MR; Savale L; Guignabert C
    FASEB J; 2019 Mar; 33(3):3670-3679. PubMed ID: 30481487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model.
    de Raaf MA; Kroeze Y; Middelman A; de Man FS; de Jong H; Vonk-Noordegraaf A; de Korte C; Voelkel NF; Homberg J; Bogaard HJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1164-73. PubMed ID: 26386116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice.
    Zhang G; Kang Y; Cathey D; LeBlanc AJ; Cai J; Cai L; Wang S; Huang J; Keller BB
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):425-436. PubMed ID: 35157168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
    Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.